查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930163

全球伴侣动物疫苗市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Companion Animal Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

伴侣动物疫苗市场成长因素

受宠物饲养量增加、动物照护水准提高以及动物健康意识增强的推动，全球伴侣动物疫苗市场正经历显着成长。该市场规模在2025年达到56.7亿美元，预计2026年将成长至59.4亿美元，并在2034年达到103.5亿美元，预测期内年复合成长率（CAGR）为7.19%。北美地区凭藉其先进的兽医基础设施、完善的疫苗接种计划以及Zoetis Services LLC、Elanco和Virbac等主要公司的存在，在2025年将以43.55%的市场占有率领先。

伴侣动物疫苗在保护宠物免受传染病侵害、提高宠物生活品质以及减少昂贵治疗需求方面发挥着非常重要的作用。它们对于遏制牲畜传染病的发生和确保动物整体健康也非常重要。

市场驱动因素

伴侣动物疫苗市场成长的主要驱动因素如下：

  • 宠物饲养量增加：全球犬、猫和其他伴侣动物饲养量的成长推动了疫苗需求。例如，在加拿大，2019年至2021年间，犬隻数量从 760万隻增加到 770万隻。
  • 策略合作与产品发布：Elanco 和 Zoetis 等公司积极推出新疫苗并进行合作研究计画。
  • 对人畜共通传染病的认识不断提高：宠物主人越来越意识到预防保健的重要性。
  • 新兴兽医基础设施和宠物保险：不断扩大的宠物保险计划鼓励定期接种疫苗和预防性护理。

市场限制因子

限制市场成长的因素：

  • 发展中国家兽医服务取得受限：地理、经济和基础设施的挑战降低疫苗接种覆盖率。在某些地区，只有大约 40%的兽医遵循现行的疫苗接种指南。
  • 高昂的研发成本：疫苗研发、临床试验和监管核准需要大量投资。
  • 监管障碍：严格的安全性和有效性标准延长了产品审批时间。
  • 物流挑战：维持疫苗配送的冷链增加了复杂性和成本，尤其是在农村和低度开发地区。

市场机会

  • 宠物保险普及率上升：随着宠物越来越被视为家庭成员，涵盖常规疫苗接种的宠物保险计划为市场成长奠定了坚实的基础。例如，Future Generali India 在2022年第四季售出了约 25,000 份宠物保险保单，凸显了市场扩张的潜力。
  • 技术进步：重组疫苗和 DNA 疫苗等创新技术使得疫苗接种计划能够更广泛、更有效地实施。

市场趋势

  • 关注健康：宠物主人越来越倾向于透过疫苗预防疾病，而非治疗疾病。
  • 创新疫苗上市：例如，Boehringer Ingelheim于2024年 11月推出了犬钩端螺旋体病疫苗 EURICAN L4。
  • 联合疫苗：能够预防多种疾病的多价疫苗提高了接种依从性和便利性。

市场区隔分析

依产品类型

  • 减毒活疫苗因其持久的免疫反应和频繁的新产品上市而占据市场主导地位。
  • 灭活疫苗位居第二。
  • 重组疫苗因其高效性和靶向多种病原体的能力，预计将以最高的年复合成长率成长。

依动物种类

  • 犬类疫苗因其高普及率和不断提高的医疗意识而引领市场。
  • 猫类疫苗由于猫的数量不断增加以及新产品（例如于2024年9月上市的NOBIVAC NXT FeLV）的出现而快速成长。
  • 其他动物（例如兔子和雪貂）的疫苗也在推动其细分市场的成长。

依给药途径

  • 注射疫苗因其疗效显着且免疫反应强劲而占据主导地位。
  • 口服疫苗因其给药方便且能产生黏膜免疫，其应用成长，尤其是在流浪动物领域。
  • 其他给药途径（鼻内、经皮）也成为便捷的替代方案。

依通路

  • 兽医诊所占据最大的市场占有率，这主要得益于诊所数量的成长以及对专业兽医护理的需求。
  • 兽医院和药局的市场占有率也在稳定成长。

区域因素

  • 北美：到2025年，北美市场规模达到24.8亿美元，其中美国将占据主导地位。 美国拥有先进的兽医设施和疫苗接种计划。
  • 欧洲：第二大市场，主要得益于英国、德国和法国较高的宠物拥有率以及政府的扶持政策。
  • 亚太地区：成长最快的地区，主要得益于可支配收入的成长、宠物拥有率的提高以及兽医基础设施的不断完善。
  • 拉丁美洲、中东和非洲：由于对有效疫苗的需求增加以及兽医服务的改善，预计成长将较为温和。

主要公司

主要公司包括 Zoetis Services LLC、Elanco、Merck Animal Health、Boehringer Ingelheim、Virbac、HIPRA、Ceva、NEOGEN 和 Hester Biosciences。这些公司的成长策略包括强大的研发实力、创新产品的推出、全球扩张以及策略合作伙伴关係。主要趋势包括：

  • 2024年6月：Merck Animal Health在加拿大推出NOBIVAC NXT狂犬病产品线。
  • 2024年2月：孟买狂犬病消除计画启动流浪犬疫苗接种活动。
  • 2022年9月：Merck Animal Health收购Vence，以推动动物保健技术的发展。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家/地区动物疾病概览（2025年）
  • 主要国家/地区监理现况（2025年）
  • 主要国家/地区宠物饲养统计（2025年）
  • 各种动物疾病疫苗接种概览
  • 主要公司新产品发布
  • 主要产业趋势：併购及收购（併购）、业务合作等
  • COVID-19 对全球伴侣动物疫苗市场的影响

第5章 全球伴侣动物疫苗市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 灭活疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测：依动物种类
    • 猫
    • 狗
    • 鸟类
    • 其他
  • 市场分析、洞察与预测：依给药途径
    • 口服
    • 注射
    • 其他
  • 市场分析、洞察与预测洞察与预测：依通路划分
    • 兽医诊所
    • 兽医院
    • 药局
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美伴侣动物疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲伴侣动物疫苗市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第8章 亚太地区伴侣动物疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲伴侣动物疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美国

第10章 中东与非洲伴侣动物疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • Elanco
    • HIPRA
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Merck Animal Health
    • Zoetis Services LLC
    • Ceva
    • NEOGEN CORPORATION
    • Hester Biosciences Limited
Product Code: FBI101041

Growth Factors of companion animal vaccines Market

The global companion animal vaccines market is witnessing significant growth, driven by rising pet ownership, advancements in veterinary healthcare, and increasing awareness of animal health. The market was valued at USD 5.67 billion in 2025, projected to grow to USD 5.94 billion in 2026, and expected to reach USD 10.35 billion by 2034, reflecting a CAGR of 7.19% during the forecast period. North America dominated the market in 2025 with a 43.55% share, attributed to advanced veterinary infrastructure, well-established immunization programs, and the presence of major players such as Zoetis Services LLC, Elanco, and Virbac.

Companion animal vaccines play a critical role in protecting pets from infectious diseases, improving their quality of life, and reducing the need for costly treatments. They are essential in controlling epizootic outbreaks and ensuring overall animal health.

Market Drivers

The growth of the companion animal vaccines market is primarily driven by:

  • Increasing pet ownership: The rising adoption of dogs, cats, and other companion animals globally drives vaccine demand. For example, in Canada, the dog population increased from 7.6 million to 7.7 million between 2019 and 2021.
  • Strategic collaborations and product launches: Companies such as Elanco and Zoetis are actively launching new vaccines and partnering on research initiatives.
  • Growing awareness of zoonotic diseases: Pet owners increasingly recognize the importance of preventive healthcare.
  • Emerging veterinary healthcare infrastructure and pet insurance: Expansion of pet insurance programs encourages routine vaccinations and preventive care.

Market Restraints

Certain factors limit the market growth:

  • Limited access to veterinary services in developing countries: Geographic, economic, and infrastructural challenges reduce vaccine penetration. Only about 40% of veterinary practitioners follow current vaccination guidelines in some regions.
  • High development costs: Vaccine research, clinical trials, and regulatory approvals require significant investment.
  • Regulatory hurdles: Stringent safety and efficacy standards extend product approval timelines.
  • Logistical challenges: Maintaining cold chains for vaccine distribution adds complexity and cost, particularly in rural and underdeveloped areas.

Market Opportunities

  • Rising adoption of pet insurance: As pets are increasingly considered family members, pet insurance programs covering routine vaccinations create a stable growth platform. For instance, Future Generali India sold nearly 25,000 pet insurance policies in Q4 2022, highlighting the expanding market potential.
  • Technological advancements: Innovations such as recombinant and DNA vaccines enable broader and more effective immunization programs.

Market Trends

  • Focus on preventive healthcare: Pet owners are increasingly seeking vaccinations to prevent diseases rather than treat them.
  • Innovative vaccine launches: For example, in November 2024, Boehringer Ingelheim launched EURICAN L4 for leptospirosis in dogs.
  • Combination vaccines: Multivalent vaccines offering protection against multiple diseases improve compliance and convenience.

Segmentation Analysis

By Product Type

  • Live attenuated vaccines dominate due to long-lasting immune response and frequent product launches.
  • Inactivated vaccines hold the second-largest share.
  • Recombinant vaccines are expected to grow at the highest CAGR due to enhanced efficacy and ability to target multiple pathogens.

By Animal Type

  • Canine vaccines lead the market due to high adoption rates and preventive healthcare awareness.
  • Feline vaccines are growing rapidly with increased cat adoption and launches like NOBIVAC NXT FeLV in September 2024.
  • Other animals such as rabbits and ferrets are also contributing to niche market growth.

By Route of Administration

  • Parenteral vaccines dominate due to proven efficacy and strong immune responses.
  • Oral vaccines are growing due to ease of administration and mucosal immunity targeting, particularly for stray animals.
  • Other routes (intranasal, transdermal) are emerging as convenient alternatives.

By Distribution Channel

  • Veterinary clinics hold the largest market share, supported by rising numbers of clinics and professional veterinary care.
  • Veterinary hospitals and pharmacies/drug stores are also growing steadily.

Regional Insights

  • North America: Market size USD 2.48 billion in 2025, led by the U.S., with advanced veterinary facilities and immunization programs.
  • Europe: Second-largest market, driven by high pet populations in the U.K., Germany, and France, along with government initiatives.
  • Asia Pacific: Fastest-growing region due to rising disposable incomes, increasing pet adoption, and expanding veterinary infrastructure.
  • Latin America & Middle East & Africa: Moderate growth expected, supported by increasing demand for effective vaccines and improved veterinary care.

Key Industry Players

Major companies include Zoetis Services LLC, Elanco, Merck Animal Health, Boehringer Ingelheim, Virbac, HIPRA, Ceva, NEOGEN, and Hester Biosciences. Their growth strategies involve robust R&D, innovative product launches, global expansions, and strategic collaborations. Notable developments include:

  • June 2024: Merck Animal Health launched NOBIVAC NXT Rabies portfolio in Canada.
  • February 2024: Mumbai Rabies Elimination Project launched a stray dog vaccination drive.
  • September 2022: Merck Animal Health acquired Vence to advance animal health technologies.

Conclusion

The global companion animal vaccines market is projected to grow from USD 5.67 billion in 2025 to USD 10.35 billion by 2034, at a CAGR of 7.19%. Market expansion is driven by rising pet adoption, preventive healthcare awareness, technological innovations, and increasing pet insurance coverage. North America dominates, while Asia Pacific shows the fastest growth. The market is expected to benefit from new product launches, improved veterinary infrastructure, and strategic initiatives by leading industry players, ensuring better animal health and broader immunization coverage worldwide.

Segmentation By Product

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Animal Type

  • Feline
  • Canine
  • Avian
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Animal Type, Route of Administration, Distribution Channel, Country/ Sub-Region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario By Key Countries/ Region, 2025
  • 4.3. Pet Ownership Statistics, By Key Countries/ Region, 2025
  • 4.4. Overview of Vaccination for Different Animal Diseases
  • 4.5. New Product Launches, By Key Players
  • 4.6. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.7. Impact of COVID-19 on the Global Companion Animal Vaccines Market

5. Global Companion Animal Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Animal Type
    • 5.2.1. Feline
    • 5.2.2. Canine
    • 5.2.3. Avian
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Animal Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Companion Animal Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Animal Type
    • 6.2.1. Feline
    • 6.2.2. Canine
    • 6.2.3. Avian
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Animal Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Companion Animal Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Animal Type
    • 7.2.1. Feline
    • 7.2.2. Canine
    • 7.2.3. Avian
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Animal Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Companion Animal Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Animal Type
    • 8.2.1. Feline
    • 8.2.2. Canine
    • 8.2.3. Avian
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Animal Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Companion Animal Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Animal Type
    • 9.2.1. Feline
    • 9.2.2. Canine
    • 9.2.3. Avian
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Animal Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Companion Animal Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Animal Type
    • 10.2.1. Feline
    • 10.2.2. Canine
    • 10.2.3. Avian
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Animal Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Elanco
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. HIPRA
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Boehringer Ingelheim International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Virbac
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Merck Animal Health
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Zoetis Services LLC
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Ceva
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. NEOGEN CORPORATION
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Hester Biosciences Limited
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 3: Global Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
  • Table 4: Global Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: North America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 8: North America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
  • Table 9: North America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Companion Animal Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Europe Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 13: Europe Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
  • Table 14: Europe Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Companion Animal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 17: Asia Pacific Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 18: Asia Pacific Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
  • Table 19: Asia Pacific Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Companion Animal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Latin America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 23: Latin America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
  • Table 24: Latin America Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Companion Animal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 27: Middle East & Africa Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 28: Middle East & Africa Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Route of Administration 2021-2034
  • Table 29: Middle East & Africa Companion Animal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Companion Animal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Companion Animal Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Companion Animal Vaccines Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Companion Animal Vaccines Market Value Share (%), by Animal Type, 2025 & 2034
  • Figure 4: Global Companion Animal Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Companion Animal Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Companion Animal Vaccines Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Companion Animal Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 8: North America Companion Animal Vaccines Market Value Share (%), by Product, 2025
  • Figure 9: North America Companion Animal Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 10: North America Companion Animal Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 11: North America Companion Animal Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Companion Animal Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Companion Animal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Companion Animal Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Companion Animal Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Companion Animal Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Companion Animal Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Europe Companion Animal Vaccines Market Value Share (%), by Product, 2025
  • Figure 19: Europe Companion Animal Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 20: Europe Companion Animal Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 21: Europe Companion Animal Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Companion Animal Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Companion Animal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Companion Animal Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Companion Animal Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Companion Animal Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Companion Animal Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 28: Asia Pacific Companion Animal Vaccines Market Value Share (%), by Product, 2025
  • Figure 29: Asia Pacific Companion Animal Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 30: Asia Pacific Companion Animal Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 31: Asia Pacific Companion Animal Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Companion Animal Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Companion Animal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Companion Animal Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Companion Animal Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Companion Animal Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Companion Animal Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 38: Latin America Companion Animal Vaccines Market Value Share (%), by Product, 2025
  • Figure 39: Latin America Companion Animal Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 40: Latin America Companion Animal Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 41: Latin America Companion Animal Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Companion Animal Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Companion Animal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Companion Animal Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Companion Animal Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Companion Animal Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Companion Animal Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 48: Middle East & Africa Companion Animal Vaccines Market Value Share (%), by Product, 2025
  • Figure 49: Middle East & Africa Companion Animal Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 50: Middle East & Africa Companion Animal Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 51: Middle East & Africa Companion Animal Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Companion Animal Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Companion Animal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Companion Animal Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Companion Animal Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Companion Animal Vaccines Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Companion Animal Vaccines Market Share (%), By Company, 2025